Page last updated: 2024-10-30

ketotifen and Bronchial Diseases

ketotifen has been researched along with Bronchial Diseases in 2 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Bronchial Diseases: Diseases involving the BRONCHI.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohshima, E1
Otaki, S1
Sato, H1
Kumazawa, T1
Obase, H1
Ishii, A1
Ishii, H1
Ohmori, K1
Hirayama, N1
Forche, G1
Zenker, G1

Other Studies

2 other studies available for ketotifen and Bronchial Diseases

ArticleYear
Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivatives.
    Journal of medicinal chemistry, 1992, May-29, Volume: 35, Issue:11

    Topics: Animals; Benzoxepins; Bronchial Diseases; Cerebellum; Constriction, Pathologic; Dibenzoxepins; Guine

1992
Influence of drug therapy on bronchial hyperreactivity.
    International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23, Issue:6

    Topics: Adult; Blood Pressure; Bronchial Diseases; Bronchial Provocation Tests; Female; Heart Rate; Histamin

1985